Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Mar 2007

Teofili Luciana, Giona Fiorina, Martini Maurizio, Cenci Tonia, Guidi Francesco, Torti Lorenza, Palumbo Giovanna, Amendola Angela, Foà Robin, Larocca Luigi M

Abstract excerpt

PURPOSE: Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence. PATIENTS AND METHODS: Thirty-eight children with PV and ET were investigated. The control group...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Erythroid Precursor Cells
Share to GPI-Linked Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoantigens

Share to Polycythemia Vera

Share to Receptors, Erythropoietin

Share to Receptors, Thrombopoietin

Share to Thrombocythemia, Essential

Share to Thrombopoietin

Source

Identifiers

PMID: 17369568
DOI: 10.1200/JCO.2006.08.6884

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.PMID 17369568Read ↗

Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.Semantic proximity Read ↗

Molecular Characterization of Polycythemia VeraSemantic proximity Read ↗

Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort.Semantic proximity Read ↗

Essential thrombocythemia A retrospective case series.Semantic proximity Read ↗

Lessons from familial myeloproliferative disorders.Semantic proximity Read ↗

Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera.Semantic proximity Read ↗

Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.Semantic proximity Read ↗

Polycythaemia vera: molecular genetics, diagnostics and therapeutics.Semantic proximity Read ↗

Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohortSemantic proximity Read ↗

Familial chronic myeloproliferative disorders: the state of the art.Semantic proximity Read ↗

The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemiaSemantic proximity Read ↗

Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.